Harris Matthew J, Le Couteur David G, Arias Irwin M
ANZAC Research Institute, University of Sydney and Center for Education and Research on Aging, Concord Repatriation General Hospital, Sydney, NSW, Australia.
J Gastroenterol Hepatol. 2005 Jun;20(6):807-17. doi: 10.1111/j.1440-1746.2005.03743.x.
Progressive familial intrahepatic cholestasis types 1, 2 and 3 are childhood diseases of the liver. Benign recurrent intrahepatic cholestasis is predominantly an adult form with similar clinical symptoms that spontaneously resolve. These genetic disorders have significantly helped to unravel the basic mechanisms of the canalicular bile transport processes. Progressive familial intrahepatic cholestasis type 1 involves a gene also linked to benign recurrent intrahepatic cholestasis. The gene codes for an aminophospholipid translocase protein that maintains the integrity of the membrane. How a mutation in this protein causes cholestasis is unknown but is thought to involve the enterohepatic recirculation of bile acids. Progressive familial intrahepatic cholestasis types 2 and 3 involve the canalicular bile salt export pump and a phospholipid translocase, respectively, both of which are fundamental to bile secretion. This review covers the clinical manifestations, genetics, treatment and mechanism of each disease.
1型、2型和3型进行性家族性肝内胆汁淤积症是儿童期肝脏疾病。良性复发性肝内胆汁淤积症主要为成人形式,具有相似的临床症状,可自发缓解。这些遗传性疾病极大地帮助揭示了胆小管胆汁转运过程的基本机制。1型进行性家族性肝内胆汁淤积症涉及一个也与良性复发性肝内胆汁淤积症相关的基因。该基因编码一种维持膜完整性的氨基磷脂转位酶蛋白。该蛋白中的突变如何导致胆汁淤积尚不清楚,但认为与胆汁酸的肠肝循环有关。2型和3型进行性家族性肝内胆汁淤积症分别涉及胆小管胆汁盐输出泵和一种磷脂转位酶,二者对胆汁分泌均至关重要。本综述涵盖了每种疾病的临床表现、遗传学、治疗方法及发病机制。